daratumumab,talquetamab,teclistamab
genmab,janssen
['multiple myeloma', 'mmsm', 'talquetamab', 'teclistamab']
teclistamab/talquetamab is tolerable with high response rate for r/r multiple myeloma #asco23 #mmsm
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more